Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-25 Sale |
2025-06-27 5:12 pm |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
57,292 | $0 | $0 | 0 (Indirect) |
View |
| 2025-06-25 Sale |
2025-06-27 5:12 pm |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
67,233 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:11 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
64,635 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:09 pm |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
57,292 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:06 pm |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
115,555 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:06 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
83,125 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:05 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
571,558 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:03 pm |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
114,584 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:02 pm |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
62,500 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:01 pm |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
114,584 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
75,565 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-25 Sale |
2025-06-27 4:58 pm |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
140,228 | $0 | $0 | 0 (Direct) |
View |
| 2025-06-03 Purchase |
2025-06-04 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
12,000 | $7.9877 | $95,852 | 48,055 (Direct) |
View |
| 2025-01-30 Purchase |
2025-01-31 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
50,000 | $1.0852 | $54,260 | 1,610,808 (Direct) |
View |
| 2025-01-30 Purchase |
2025-01-31 5:00 pm |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
19,610 | $1.06 | $20,787 | 22,169 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
43,635 | $1.2632 | $55,120 | 49,546 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
127,054 | $1.2632 | $160,495 | 210,808 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 5:00 pm |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
43,804 | $1.2632 | $55,333 | 45,478 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 5:00 pm |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
31,445 | $1.2632 | $39,721 | 36,055 (Direct) |
View |
| 2024-07-25 Purchase |
2024-07-29 4:18 pm |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
4,000 | $1.82 | $7,280 | 6,740 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-25 Equity Swap |
2025-06-27 5:12 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
44,264 | $0 | 0 (Indirect) |
View |
| 2025-06-25 Equity Swap |
2025-06-27 5:11 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
976,253 | $0 | 0 (Direct) |
View |
| 2025-06-25 Equity Swap |
2025-06-27 5:09 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
6,979 | $0 | 0 (Direct) |
View |
| 2025-06-25 Equity Swap |
2025-06-27 5:06 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
60,796 | $0 | 0 (Direct) |
View |
| 2025-06-25 Equity Swap |
2025-06-27 5:03 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
32,585 | $0 | 0 (Direct) |
View |
| 2025-06-25 Equity Swap |
2025-06-27 5:01 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
32,585 | $0 | 0 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-18 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
4,000 | $9.9 | 65,519 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-18 5:00 pm |
2022-06-09 2031-06-13 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
6,325 | $0 | 65,519 (Direct) |
View |
| 2025-06-17 Exercise |
2025-06-18 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
2,325 | $8.8 | 65,519 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 6:16 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
62,500 | $0 | 1,040,888 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
62,500 | $0 | 147,169 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
62,500 | $0 | 147,169 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
62,500 | $0 | 67,233 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
62,500 | $0 | 69,240 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
62,500 | $0 | 64,271 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
62,500 | $0 | 101,556 (Indirect) |
View |
| 2025-01-30 Option Award |
2025-01-31 5:00 pm |
N/A 2035-01-29 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
1,350,000 | $0 | 1,610,808 (Direct) |
View |
| 2025-01-30 Option Award |
2025-01-31 5:00 pm |
N/A 2035-01-29 |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
675,000 | $0 | 675,000 (Direct) |
View |
| 2025-01-30 Option Award |
2025-01-31 5:00 pm |
N/A 2035-01-29 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
487,500 | $0 | 487,500 (Direct) |
View |
| 2025-01-30 Option Award |
2025-01-31 5:00 pm |
N/A 2035-01-29 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
562,500 | $0 | 562,500 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
218,750 | $1.36 | 337,862 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer |
62,000 | $1.3 | 337,862 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
62,500 | $1.36 | 89,282 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
21,000 | $1.3 | 89,282 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
66,625 | $1.36 | 93,181 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
17,500 | $1.3 | 93,181 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
37,500 | $1.36 | 67,500 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
30,000 | $1.3 | 67,500 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:24 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
60,000 | $0 | 60,000 (Indirect) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:23 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:23 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:23 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
60,000 | $0 | 60,000 (Direct) |
View |